February 26, 2021By Mel J. YeatesThermo Fisher acquires Mesa BiotechThermo Fisher has completed the acquisition of Mesa Biotech and its Accula System PCR testing platform
Other Internal MedicineFebruary 25, 2021By DDN StaffMore of a good thingINOVIO, QIAGEN expand their existing collaboration to cover companion diagnostics for INVOIO's HPV therapies
February 24, 2021By Lori LeskoSpecifica sells antibody library platform to UCBThe Generation 3 Library Platform will boost UCB’s discovery efforts
February 24, 2021By Kevin NoonanPatent Docs: Patent interference parties provide evidence for priorityThe arguments over "first to invent" and ownership of CRISPR tech continue
February 23, 2021By DDN StaffA commercialization agreement for ibrexafungerpIbrexafungerp on track for FDA approval in June for vaginal yeast infections
Tools & Techniques NewsFebruary 19, 2021By DDN StaffThermo Fisher boosts cell sorting capabilitiesThe company has acquired assets from Propel Labs, including the Bigfoot Spectral Cell Sorter
February 17, 2021By DDN StaffCan microbiome-based therapeutics fight bacterial vaginosis?The collaboration plans to create stabilized live microbiota-based formulations for treating bacterial vaginosis
Tools & Techniques NewsFebruary 11, 2021By DDN StaffTurning to AI for COVID prognosesBiodesix publishes paper detailing the use of its AI-based algorithm to identify COVID-19 patients who are likely to need medical intervention
February 11, 2021By DDN StaffEnsoma starts its enginesNewly launched company hits the ground running with $70M in financing and a collaboration with Takeda
Infectious Disease & VaccinesFebruary 9, 2021By Mel J. YeatesOliX launches mCureX for mRNA vaccinesOliX Pharmaceuticals spins out new subsidiary for developing mRNA vaccines and therapeutics